Trial Details

COMPLETED
Basic Information
Clinical ID c4700
Identifier NCT00101985
Trial Title Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Colon
Interventions DRUG: talnetant
Participant Information
Sponsor GlaxoSmithKline
City Chandler
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2004-10
Primary Completion Date 2005-07
Completion Date 2005-07